Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06802861 · ClinicalTrials.gov registry record

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

A clinical trial of Pregnancy and Gestational Diabetes, sponsored by University of Tennessee Graduate School of Medicine.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06802861 is a study of Pregnancy and Gestational Diabetes that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06802861, a study of Pregnancy and Gestational Diabetes, is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.

Study Locations (1)

Tennessee

  • University of Tennessee Medical Center - Knoxville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-01-01
Est. Completion 2028-12-31

What the Registry Record Tells You About NCT06802861

The ClinicalTrials.gov registry entry for NCT06802861 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT06802861 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06802861 about?

NCT06802861 is a clinical study titled "Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia". This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.

What is the current status of trial NCT06802861?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-01-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06802861 study?

This clinical trial studies the following conditions: Pregnancy, Gestational Diabetes, Preeclampsia, Pregnancy Complications, Obesity and Obesity-related Medical Conditions.

Who is sponsoring clinical trial NCT06802861?

This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06802861 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.